Investor Relations

Partnering to Preserve Vision, Globally

At RetinaX.ai, we’re pioneering the future of retinal diagnostics by merging artificial intelligence with clinical-grade accuracy. Our goal is simple yet powerful: to make early detection of preventable eye diseases accessible worldwide — faster, smarter, and more affordable.

We are proud to be at the forefront of AI-driven medical imaging, addressing a global health challenge with transformative technology. As we scale our solution across new markets and expand our diagnostic capabilities, we’re actively seeking visionary investors who share our mission.

Why Invest in RetinaX.ai?

  • Proven AI Platform: Clinically validated deep learning models with more accuracy

  • Scalable Technology: Cloud-based + edge-compatible for global deployments

  • Global Demand: Addressing growing diabetic and aging populations worldwide

  • Regulatory Roadmap: Designed to meet FDA, CE, and other international standards

  • Experienced Team: Cross-functional leadership in AI, ophthalmology, and healthtech

  • Impact-Driven: Delivering equitable eye care through partnerships, telehealth, and NGO programs

What We’re Building Toward

  • Expanded diagnostic modules (e.g., glaucoma, myopic degeneration)

  • Mobile and telehealth integrations

  • Deployment in hospitals, clinics, and rural outreach programs

  • Strategic global partnerships and enterprise health clients

  • Regulatory approvals and clinical trial expansion

Get in Touch

Interested in learning more about our current funding round, financials, or growth strategy? Please contact us today, We look forward to partnering with those who see the future — and believe in building it.